CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Jun 02, 2023. (Total: 4311 publications since 2011)

All Cancer Diabetes Economic Environmental Equity FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search CDC Author Year Journal

Records 1-18 (of 18 Records)

Query Trace: all>>Tom T Shimabukuro[CDC Author]
COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months-5 Years - United States, June 18, 2022-August 21, 2022. Hause AM , Marquez P , Zhang B , Myers TR , Gee J , Su JR , Parker C , Thompson D , Panchanathan SS , Shimabukuro TT , Shay DK . MMWR Morb Mortal Wkly Rep 2022 71 (35) 1115-1120
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022. Hause AM , Baggs J , Marquez P , Myers TR , Su JR , Hugueley B , Thompson D , Gee J , Shimabukuro TT , Shay DK . MMWR Morb Mortal Wkly Rep 2022 71 (33) 1047-1051
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. Oster ME , Shay DK , Su JR , Gee J , Creech CB , Broder KR , Edwards K , Soslow JH , Dendy JM , Schlaudecker E , Lang SM , Barnett ED , Ruberg FL , Smith MJ , Campbell MJ , Lopes RD , Sperling LS , Baumblatt JA , Thompson DL , Marquez PL , Strid P , Woo J , Pugsley R , Reagan-Steiner S , DeStefano F , Shimabukuro TT . JAMA 2022 327 (4) 331-340
Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system. Chapin-Bardales J , Myers T , Gee J , Shay DK , Marquez P , Baggs J , Zhang B , Licata C , Shimabukuro TT . Vaccine 2021 39 (48) 7066-7073
Surveillance for Adverse Events After COVID-19 mRNA Vaccination. Klein NP , Lewis N , Goddard K , Fireman B , Zerbo O , Hanson KE , Donahue JG , Kharbanda EO , Naleway A , Nelson JC , Xu S , Yih WK , Glanz JM , Williams JTB , Hambidge SJ , Lewin BJ , Shimabukuro TT , DeStefano F , Weintraub ES . JAMA 2021 326 (14) 1390-1399
Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines. Shay DK , Shimabukuro TT , DeStefano F . JAMA Cardiol 2021 6 (10) 1115-1117
Safety of the 9-Valent Human Papillomavirus Vaccine. Shimabukuro TT , Su JR , Marquez PL , Mba-Jonas A , Arana JE , Cano MV . Pediatrics 2019 144 (6)
Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017. Suragh TA , Lewis P , Arana J , Mba-Jonas A , Li R , Stewart B , Shimabukuro TT , Cano M . Br J Clin Pharmacol 2018 84 (12) 2928-2932
Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015. Miller ER , Lewis P , Shimabukuro TT , Su J , Moro P , Woo EJ , Jankosky C , Cano M . Hum Vaccin Immunother 2018 14 (8) 1-23
Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015. Arana JE , Harrington T , Cano M , Lewis P , Mba-Jonas A , Rongxia L , Stewart B , Markowitz LE , Shimabukuro TT . Vaccine 2018 36 (13) 1781-1788
Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System. Arana Jorge, Mba-Jonas Adamma, Jankosky Christopher, Lewis Paige, Moro Pedro L, Shimabukuro Tom T, Cano Maria. The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2017 Nov 61(5) 577-582 . The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2017 Nov 61(5) 577-582
Safety of Second-Dose Single-Antigen Varicella Vaccine. Su John R, Leroy Zanie, Lewis Paige W, Haber Penina, Marin Mona, Leung Jessica, Woo Emily Jane, Shimabukuro Tom T. Pediatrics 2017 Mar 139(3) . Pediatrics 2017 Mar 139(3)
Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013. Miller Elaine R, Moro Pedro L, Cano Maria, Lewis Paige, Bryant-Genevier Marthe, Shimabukuro Tom T. Vaccine 2016 34(25) 2841-6 . Vaccine 2016 34(25) 2841-6
Surveillance of adverse events after the first trivalent inactivated influenza vaccine produced in mammalian cell culture (Flucelvax(®)) reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013-2015. Moro Pedro L, Winiecki Scott, Lewis Paige, Shimabukuro Tom T, Cano Maria. Vaccine 2015 Nov 33(48) 6684-8 . Vaccine 2015 Nov 33(48) 6684-8
Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014. Haber Penina, Moro Pedro L, Cano Maria, Lewis Paige, Stewart Brock, Shimabukuro Tom T. Vaccine 2015 Apr 33(16) 1987-92 . Vaccine 2015 Apr 33(16) 1987-92
Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013. Sukumaran Lakshmi, McNeil Michael M, Moro Pedro L, Lewis Paige W, Winiecki Scott K, Shimabukuro Tom T. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015 May 60(10) e58-65 . Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015 May 60(10) e58-65
Adverse events following Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990-2013. Moro Pedro L, Jankosky Christopher, Menschik David, Lewis Paige, Duffy Jonathan, Stewart Brock, Shimabukuro Tom T. The Journal of pediatrics 2015 Apr 166(4) 992-7 . The Journal of pediatrics 2015 Apr 166(4) 992-7
Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013. Haber Penina, Moro Pedro L, McNeil Michael M, Lewis Paige, Woo Emily Jane, Hughes Hayley, Shimabukuro Tom T. Vaccine 2014 Nov 32(48) 6499-504 . Vaccine 2014 Nov 32(48) 6499-504